We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

75 hedge funds and large institutions have $971M invested in Vaxcyte in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 35 increasing their positions, 16 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 16

12% more capital invested

Capital invested by funds: $868M → $971M (+$103M)

1% more funds holding

Funds holding: 74 → 75 (+1)

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

1.64% less ownership

Funds ownership: 85.76% → 84.12% (-1.6%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
75
Holders Change
+1
Holders Change %
+1.35%
% of All Funds
1.31%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
12
Increased
35
Reduced
16
Closed
11
Calls
$254K
Puts
–
Net Calls
+$254K
Net Calls Change
-$106K

Top Buyers

1
O
OrbiMed
New York
+$6.07M
2
BlackRock
BlackRock
New York
+$3.23M
3
GTC
Ghost Tree Capital
New York
+$2.97M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.01M
5
SCM
Soleus Capital Management
Connecticut
+$1.68M

Top Sellers

1
PA
Perceptive Advisors
New York
-$16.8M
2
NHAS
Novo Holdings A/S
Denmark
-$8.23M
3
State Street
State Street
Massachusetts
-$5.5M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.46M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$2.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
26
Sabby Management
Florida
$2.66M -$1.25M -60,998 -34%
UBS Group
27
UBS Group
Switzerland
$2.43M -$155K -7,547 -7%
Citadel Advisors
28
Citadel Advisors
Florida
$2.12M -$345K -16,840 -15%
Citigroup
29
Citigroup
New York
$1.91M -$580K -28,311 -25%
Bank of America
30
Bank of America
North Carolina
$1.77M +$601K +29,344 +60%
Voloridge Investment Management
31
Voloridge Investment Management
Florida
$1.58M +$432K +21,095 +43%
ERSOT
32
Employees Retirement System of Texas
Texas
$1.32M +$1.2M +58,441 New
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$1.23M +$227K +11,092 +25%
Rafferty Asset Management
34
Rafferty Asset Management
New York
$1.19M -$775K -37,877 -42%
AAA
35
Affinity Asset Advisors
New York
$1.13M +$409K +20,000 +67%
BFM
36
Boothbay Fund Management
New York
$1.11M -$119K -5,810 -11%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$1.02M +$343K +16,763 +59%
Swiss National Bank
38
Swiss National Bank
Switzerland
$1.01M +$213K +10,400 +30%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$773K +$271K +13,252 +63%
AllianceBernstein
40
AllianceBernstein
Tennessee
$680K +$160K +7,800 +35%
Deutsche Bank
41
Deutsche Bank
Germany
$668K +$216K +10,545 +55%
PPA
42
Parametric Portfolio Associates
Washington
$585K +$532K +25,978 New
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$515K +$128K +6,249 +38%
JP Morgan Chase
44
JP Morgan Chase
New York
$493K -$882K -43,064 -66%
Morgan Stanley
45
Morgan Stanley
New York
$449K +$213K +10,405 +110%
ProShare Advisors
46
ProShare Advisors
Maryland
$440K +$97.2K +4,750 +32%
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$426K +$388K +18,936 New
Squarepoint
48
Squarepoint
New York
$372K +$338K +16,504 New
VOYA Investment Management
49
VOYA Investment Management
Georgia
$353K +$71.1K +3,474 +28%
EMG
50
ETF Managers Group
New Jersey
$342K -$9.23K -451 -3%
1
2
3 4

PCVX Hedge Fund Activity: Q2 2021 in Review

75 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q2 2021, worth a combined $971M — up 12% from $868M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new PCVX positions and 11 closed out — a net gain of 1 holder — while 35 added to existing stakes and 16 trimmed.

The largest buyer was OrbiMed, adding an estimated $6.07M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $16.8M sold.

  • 75 institutional investors held Vaxcyte (PCVX) as of Q2 2021, up from 74 in Q1 2021.
  • Funds reported $971M of Vaxcyte stock for Q2 2021, up 12% quarter-over-quarter.
  • 12 funds opened new Vaxcyte positions in Q2 2021 and 11 closed out, a net change of +1 holder.
  • The largest Vaxcyte buyer in Q2 2021 was OrbiMed, an estimated $6.07M added.
  • The largest Vaxcyte seller in Q2 2021 was Perceptive Advisors, an estimated $16.8M sold.

Based on aggregated 13F filings for Q2 2021.